When dementia is diagnosed early on, there are more treatment and management options.Dr. Sudha Seshadri — the founding director of the Alzheimer’s and neurodegenerative diseases institute at UT Health ...

Every person is presumed to have the capacity to manage their own affairs and make their own decisions up until the court has adjudicated them as an incapacitated individual incapable of communicating ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Alzinova AB (publ) (ticker: ALZ) announces that another milestone in the development of the company's vaccine candidate ALZ-101 for Alzheimer's disease has been reached. All study participants have no ...

These questions will now be discussed at the CHMP meeting in February 2025, before the Commission can take a final decision on the Marketing Authorization Application for lecanemab as treatment for ...

Scientists led by the Institute of Nanotechnology in Italy, in collaboration with the ESRF, the European Synchrotron in Grenoble, France, have discovered how X-ray micro- and nano- tomography can ...

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

An emergency room doctor has shared the 10 early warning signs you or a loved one might have developed Alzheimer's disease - as he urges people to visit their doctors ...

The 2025 Walk to End Alzheimer’s will feature the poignant Promise Garden ceremony, where participants carry flowers of various colors symbolizing their personal connection to the disease ...

This blood test is designed to aid healthcare providers identify patients with amyloid pathology associated with Alzheimer's disease. "We are honored to receive Breakthrough Device Designation ...